PL354365A1 - Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions - Google Patents

Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions

Info

Publication number
PL354365A1
PL354365A1 PL00354365A PL35436500A PL354365A1 PL 354365 A1 PL354365 A1 PL 354365A1 PL 00354365 A PL00354365 A PL 00354365A PL 35436500 A PL35436500 A PL 35436500A PL 354365 A1 PL354365 A1 PL 354365A1
Authority
PL
Poland
Prior art keywords
pharmaceutical compositions
amino acid
topical pharmaceutical
fatty acid
antimicrobial effectiveness
Prior art date
Application number
PL00354365A
Other languages
Polish (pl)
Inventor
Ernesto J. Castillo
Steven Howard Gerson
Wesley Wehsin Han
Original Assignee
Alcon Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories, Inc. filed Critical Alcon Laboratories, Inc.
Publication of PL354365A1 publication Critical patent/PL354365A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL00354365A 1999-09-21 2000-09-11 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions PL354365A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39901399A 1999-09-21 1999-09-21

Publications (1)

Publication Number Publication Date
PL354365A1 true PL354365A1 (en) 2004-01-12

Family

ID=23577764

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00354365A PL354365A1 (en) 1999-09-21 2000-09-11 Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions

Country Status (10)

Country Link
EP (1) EP1214094A1 (en)
JP (1) JP2003509474A (en)
CN (1) CN1374874A (en)
AR (1) AR025713A1 (en)
AU (1) AU7363700A (en)
BR (1) BR0014117A (en)
CA (1) CA2391976A1 (en)
PL (1) PL354365A1 (en)
TR (1) TR200200724T2 (en)
WO (1) WO2001021209A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444710B1 (en) 1998-10-27 2002-09-03 Alcon Manufacturing, Ltd. Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
FR2837710B1 (en) * 2002-03-26 2005-07-08 Innovations Pharma Ag TOPICAL COMPOSITION BASED ON ION-EXCHANGE RESINS, IN PARTICULAR FOR THE TREATMENT OF ERYTHEMES
JP5642929B2 (en) * 2005-03-10 2014-12-17 スリーエム イノベイティブ プロパティズ カンパニー Method for reducing minute biological contamination
CN103079595B (en) * 2010-08-27 2015-11-25 若素制药株式会社 Eye drip use compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209722C3 (en) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Dripable gel for ophthalmology
US5520920A (en) * 1992-08-28 1996-05-28 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
US5504113A (en) * 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
JPH0977725A (en) * 1995-09-13 1997-03-25 Ajinomoto Co Inc Production of lysine salt of fatty acid
CA2340225A1 (en) * 1998-10-27 2000-05-04 Wesley Wehsin Han Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap

Also Published As

Publication number Publication date
TR200200724T2 (en) 2002-06-21
EP1214094A1 (en) 2002-06-19
AU7363700A (en) 2001-04-24
BR0014117A (en) 2002-05-14
CN1374874A (en) 2002-10-16
JP2003509474A (en) 2003-03-11
AR025713A1 (en) 2002-12-11
WO2001021209A1 (en) 2001-03-29
CA2391976A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
PL354364A1 (en) Anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions
HU0303037D0 (en) Compounds to treat alzheimer's disease and pharmaceutical compositions containing them
HK1149719A1 (en) Ciclesonide contained pharmaceutical composition for application to mucosa
HUP0202342A3 (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
HUP0303881A3 (en) Pharmaceutical compositions containing fatty alcohols and fatty acid esters useful for treatment of inflammation
HUP0300080A3 (en) Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
HUP0002512A3 (en) Medicinal compositions for application to mucosa
HUP0203311A3 (en) New pharmaceutical compositions of prolonged effect
HUP0202184A3 (en) Propanoic acid derivatives that inhibit the binding of integrins to their receptors, pharmaceutical compositions containing them and their use
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
PL1660047T3 (en) Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
ZA9711163B (en) Mild antimicrobial liquid cleansing formulations comprising hydroxy acid buffering compound or compounds as potentiator of antimicrobial effectiveness
HUP0203884A3 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics and pharmaceutical compositions containing them
PL354365A1 (en) Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions
HUP0203226A3 (en) Pharmaceutical composition comprising benzamide derivative as active ingredient
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
HUP0203187A3 (en) Isoxazole derivatives to be used as phosphodiesterase vii inhibitors and pharmaceutical compositions containing them
FR2794023B1 (en) COSMETIC COMPOSITION FOR ENHANCING THE EFFECTIVENESS OF THE ACTIVE INGREDIENTS OF OTHER COSMETIC COMPOSITIONS
IL131355A0 (en) Use of pivagabin to prepare pharmaceutical compositions
HUP0400075A2 (en) Preparation of pharmaceutical compositions to treat ahdh
AU5957600A (en) Pharmaceutical compositions for topical application to treat erectile dysfunction
HUP0400531A3 (en) Hydantoin compounds useful as anti-inflammatory agents and pharmaceutical compositions containing them
HUP0102705A3 (en) Alpha-amino acid phenyl ester derivatives and their use and pharmaceutical compositions comprising them
HUP0102702A3 (en) Pharmaceutical composition on the basis of erythromycin fatty acid salts for the topical treatment of skin diseases
ATA171599A (en) PHARMACEUTICAL COMPOSITION TO MEET THE BASIC NEEDS OF VITAMINS